2002
DOI: 10.1016/s0041-0101(01)00194-5
|View full text |Cite
|
Sign up to set email alerts
|

Gossypol, a component in cottonseed, induced increases in cytosolic Ca 2+ levels in Chang liver cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
15
0

Year Published

2002
2002
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 12 publications
(18 citation statements)
references
References 21 publications
3
15
0
Order By: Relevance
“…This value is similar to the 10 lM observed in breast cancer cells, bladder cancer cells and renal tubular cells (Chang et al 2001(Chang et al , 2002Jan et al 2000). Tamoxifen increased [Ca 2+ ] i by releasing store-Ca 2+ and causing Ca 2+ influx because removing extracellular Ca 2+ partly reduced the tamoxifen-induced [Ca 2+ ] i increase.…”
Section: Discussionsupporting
confidence: 85%
See 3 more Smart Citations
“…This value is similar to the 10 lM observed in breast cancer cells, bladder cancer cells and renal tubular cells (Chang et al 2001(Chang et al , 2002Jan et al 2000). Tamoxifen increased [Ca 2+ ] i by releasing store-Ca 2+ and causing Ca 2+ influx because removing extracellular Ca 2+ partly reduced the tamoxifen-induced [Ca 2+ ] i increase.…”
Section: Discussionsupporting
confidence: 85%
“…Our results suggest that tamoxifen released Ca 2+ solely from thapsigargin-sensitive endoplasmic reticulum store, similar to the case in breast cancer cells, bladder cancer cells and renal tubular cells (Chang et al 2001(Chang et al , 2002Jan et al 2000). Our data also suggest that ryanodine-sensitive Ca 2+ stores did not contribute to tamoxifen-induced Ca 2+ release.…”
Section: Discussionsupporting
confidence: 81%
See 2 more Smart Citations
“…To further test the suitability of our strategy for enhancing drug accumulation, we tested the sensitivity of a panel of 80 approved or experimental anticancer agents obtained from Discovery Microsource. This set of compounds includes DNA damaging agents, topoisomerase inhibitors, and compounds acting by unknown mechanisms such as garlicin and agents that do not damage DNA such as gossypol (Cheng et al, 2002;Qiu et al, 2002). The set of compounds also includes agents that would not act in yeast (such as nucleoside analogs) because of the absence of appropriate activating enzymes.…”
Section: Suppressing Drug Resistance Genes In Yeast 427mentioning
confidence: 99%